Polycystic ovary syndrome (PCOS) is the most common hormonal disorder affecting women of reproductive age, impacting approximately 10% of women globally. Despite its name, PCOS is primarily a hormonal and metabolic condition — not just an ovarian problem. It causes irregular menstrual cycles, elevated androgens (causing acne and excess hair growth), and often polycystic ovary appearance on ultrasound, alongside metabolic complications including insulin resistance, obesity, and elevated cardiovascular risk. Medical clinics — particularly OB-GYN and endocrinology practices — provide comprehensive PCOS management. This guide explains clinical care for PCOS.
PCOS Diagnosis
The Rotterdam criteria require at least two of three features for PCOS diagnosis: irregular or absent menstrual cycles, clinical or biochemical signs of elevated androgens (acne, excess facial/body hair, elevated testosterone), and polycystic ovary appearance on ultrasound. Other conditions causing similar features (thyroid disease, hyperprolactinemia, adrenal disorders) must be excluded through blood tests.
Treatment Goals and Approaches
Menstrual Regulation
Combined oral contraceptives (birth control pills) regulate menstrual cycles, reduce androgen levels (improving acne and hair growth), and protect against endometrial hyperplasia in women with infrequent periods. Progestin-only or cyclical progestin therapy provides menstrual regulation when estrogen is contraindicated.
Fertility
For women with PCOS seeking pregnancy, ovulation induction is typically necessary. Letrozole is the current first-line ovulation induction agent, with clomiphene citrate as an alternative. Metformin improves ovulation response in insulin-resistant patients. Assisted reproductive technologies are available when ovulation induction fails.
Metabolic Management
Lifestyle intervention (5–10% weight loss through diet and exercise) significantly improves hormonal and metabolic parameters in overweight women with PCOS. Metformin reduces insulin resistance and improves hormonal profiles. Addressing metabolic risk factors (obesity, pre-diabetes, dyslipidemia) reduces long-term cardiovascular and diabetes risk.
Conclusion
PCOS is a lifelong condition requiring individualized management based on current priorities — menstrual regulation, fertility, acne management, or metabolic health — which evolve throughout a woman’s life. Consistent clinic care provides the monitoring and treatment adjustments that keep PCOS well-managed across these changing life stages.
FAQs – PCOS
Q1. Does PCOS cause infertility?
A: PCOS causes irregular or absent ovulation, making spontaneous conception more difficult. However, most women with PCOS can achieve pregnancy with ovulation induction treatment. It is a cause of infertility, not permanent sterility.
Q2. Does PCOS increase cancer risk?
A: Infrequent menstrual periods (fewer than 4 per year) increase endometrial cancer risk through unopposed estrogen exposure. Regular menstrual induction — through birth control or cyclical progestin — reduces this risk by ensuring regular shedding of the uterine lining.
Q3. Can PCOS go away after menopause?
A: Hormonal symptoms improve after menopause as natural androgen and estrogen levels decline. However, the metabolic aspects of PCOS (insulin resistance, dyslipidemia, cardiovascular risk) persist and require continued management.
Q4. Is PCOS related to diabetes?
A: Yes. Insulin resistance is present in 65–70% of women with PCOS. Women with PCOS have significantly elevated risk of developing Type 2 diabetes — annual screening with fasting glucose or HbA1c is recommended.
Q5. What dietary approach is best for PCOS?
A: Low glycemic index diets that reduce blood sugar spikes are most evidence-supported for PCOS. Mediterranean dietary patterns and reducing refined carbohydrates and sugar improve insulin sensitivity and hormonal profiles. Work with a registered dietitian for individualized guidance.
